The case centers on the federal 340B program, in which drugmakers provide discounts to eligible healthcare providers that ...

Johnson & Johnson is escalating its fight with the federal government over its controversial plan to change how it doles out ...

Despite rebukes by two federal circuit courts, an HHS sub-agency continues to overstep its authority when administering a ...

The aims of the 340B program are important. But, unfortunately, there is little evidence that the program is delivering on ...

Johnson & Johnson seeks to charge 340B-enrolled disproportionate share hospitals full price for Xarelto and Stelara and issue ...

The New Jersey-based drugmaker is trying to get the courts’ backing to pay hospitals rebates for two drugs in the 340B drug ...

The Medical University of South Carolina has been awarded $1.75 million from the Health Resources and Services Administration ...

The lawsuit is the second by a large drugmaker in recent days challenging how it provides required discounts to certain ...

BROCKPORT — Oak Orchard Health plans to expand its behavioral health services in Genesee County, thanks to a $600,000 award ...

Premier alleges the Health Resources and Services Administration lacks authority to enforce a policy restricting how 340B ...

Johnson & Johnson’s rebate model aims to address misuse of 340B Program. HRSA’s threats of penalties led J&J to halt the plan ...

Drugmaker Johnson and Johnson is suing the Department of Health and Human Services and the Health Resources and Services Administration for blocking its new 340B rebate model, and is seeking to verify ...